Patents by Inventor Patrizia BALLERINI

Patrizia BALLERINI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10520491
    Abstract: Disclosed herein are cell lines transformed to express G-Protein Coupled Receptor GPCR22 and uses thereof for identifying guanosine analogues and/or other ligands to the receptor. In particular, techniques for transforming Drosophila Schneider 2 cells and human astrocytoma 1321N1 cell to express GPCR22 are disclosed as well as transformed cells lines. The transformed cell lines of the instant disclosure may be useful in identifying guanosine analogues and functional equivalents thereof.
    Type: Grant
    Filed: June 15, 2018
    Date of Patent: December 31, 2019
    Assignee: LIBRAMEN NATURALS INC.
    Inventors: Michel P. Rathbone, Shucui Jiang, Francesco Caciagli, Renata Ciccarelli, Patrizia Ballerini, Patrizia Di Iorio, Patricia Giuliani, Iolanda D'Alimonte
  • Publication number: 20180335422
    Abstract: Disclosed herein are cell lines transformed to express G-Protein Coupled Receptor GPCR22 and uses thereof for identifying guanosine analogues and/or other ligands to the receptor. In particular, techniques for transforming Drosophila Schneider 2 cells and human astrocytoma 1321N1 cell to express GPCR22 are disclosed as well as transformed cells lines. The transformed cell lines of the instant disclosure may be useful in identifying guanosine analogues and functional equivalents thereof.
    Type: Application
    Filed: June 15, 2018
    Publication date: November 22, 2018
    Applicant: LIBRAMEN NATURALS INC.
    Inventors: Michel P. RATHBONE, Shucui JIANG, Francesco CACIAGLI, Renata CICCARELLI, Patrizia BALLERINI, Patrizia DI IORIO, Patricia GIULIANI, Iolanda D'ALIMONTE
  • Patent number: 10012641
    Abstract: Disclosed herein are cell lines transformed to express G-Protein Coupled Receptor GPCR22 and uses thereof for identifying guanosine analogs and/or other ligands to the receptor. In particular, techniques for transforming Drosophila Schneider 2 cells and human astrocytoma 1321N1 cell to express GPCR22 are disclosed as well as transformed cells lines. The transformed cell lines of the instant disclosure may be useful in identifying guanosine analogs and functional equivalents thereof.
    Type: Grant
    Filed: October 21, 2016
    Date of Patent: July 3, 2018
    Assignee: LIBRAMEN NATURALS INC.
    Inventors: Michel P. Rathbone, Shucui Jiang, Francesco Caciagli, Renata Ciccarelli, Patrizia Ballerini, Patrizia Di Iorio, Patricia Giuliani, Iolanda D'Alimonte
  • Publication number: 20170115277
    Abstract: Disclosed herein are cell lines transformed to express G-Protein Coupled Receptor GPCR22 and uses thereof for identifying guanosine analogues and/or other ligands to the receptor. In particular, techniques for transforming Drosophila Schneider 2 cells and human astrocytoma 1321N1 cell to express GPCR22 are disclosed as well as transformed cells lines. The transformed cell lines of the instant disclosure may be useful in identifying guanosine analogues and functional equivalents thereof.
    Type: Application
    Filed: October 21, 2016
    Publication date: April 27, 2017
    Applicant: LIBRAMEN NATURALS INC.
    Inventors: Michel P. RATHBONE, Shucui JIANG, Francesco CACIAGLI, Renata CICCARELLI, Patrizia BALLERINI, Patrizia DI IORIO, Patricia GIULIANI, Iolanda D'ALIMONTE